NYSEAMERICAN:SENSSenseonics Stock Price, Forecast & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Senseonics.

Senseonics is scheduled to release its next quarterly earnings announcement on Tuesday, June 9th 2020. View our earnings forecast for Senseonics.

Senseonics will be holding an earnings conference call on Tuesday, June 9th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Senseonics Holdings Inc (NYSEAMERICAN:SENS) posted its quarterly earnings data on Thursday, March, 12th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.16) by $0.02. The business had revenue of $9 million for the quarter, compared to the consensus estimate of $7.93 million. View Senseonics' earnings history.

Senseonics updated its FY 2020 After-Hours earnings guidance on Thursday, March, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $15-20 million, compared to the consensus revenue estimate of $36.29 million.

8 analysts have issued 1 year price targets for Senseonics' shares. Their forecasts range from $0.25 to $2.00. On average, they anticipate Senseonics' stock price to reach $1.23 in the next year. This suggests a possible upside of 156.9% from the stock's current price. View analysts' price targets for Senseonics.

Media headlines about SENS stock have trended extremely negative recently, InfoTrie reports. The research firm identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Senseonics earned a daily sentiment score of -4.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 1.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutSenseonics.

Some companies that are related to Senseonics include Volpara Health Tech (VHT), Profound Medical (PRN), Renalytix Ai (RENX), Akumin (AKU), Exagen (XGN), Yourgene Health (YGEN), Palatin Technologies (PTN), MaxCyte (MXCT), Oncosil Medical (OSL), Lexagene (LXG), Oncimmune (ONC), Genedrive (GDR), SQI Diagnostics (SQD), BARD1 Life Sciences (BD1) and Sernova (SVA). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include Advanced Micro Devices (AMD), Agile Therapeutics (AGRX), Amarin (AMRN), Crispr Therapeutics (CRSP), Sorrento Therapeutics (SRNE), Tandem Diabetes Care (TNDM), VirnetX (VHC), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Protalix Biotherapeutics (PLX).

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics' stock is owned by many different retail and institutional investors. Top institutional shareholders include NEA Management Company LLC (13.71%), BlackRock Inc. (4.38%), State Street Corp (0.91%), Geode Capital Management LLC (0.82%), Raymond James Financial Services Advisors Inc. (0.28%) and Nuveen Asset Management LLC (0.24%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View institutional ownership trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Morgan Stanley, UBS Group AG, BlackRock Inc., Spark Investment Management LLC, Raymond James Financial Services Advisors Inc., and Rhumbline Advisers. View insider buying and selling activity for Senseonics.

SENS stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Beacon Pointe Advisors LLC, Geode Capital Management LLC, Squarepoint Ops LLC, Alliancebernstein L.P., Advisor Group Holdings Inc., Wells Fargo & Company MN, and Palisades Hudson Asset Management L.P.. View insider buying and selling activity for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.48.

Senseonics has a market capitalization of $107.11 million. Senseonics employs 191 workers across the globe.

The official website for Senseonics is www.senseonics.com.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.